• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PAVmed Inc. - Series Z Warrant (NQ:PAVMZ)

0.0009 UNCHANGED
Last Price Updated: 1:52 PM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PAVmed Inc. - Series Z Warrant

< Previous 1 2 Next >
News headline image
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
November 16, 2021
From PAVmed Inc. and Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
November 11, 2021
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021
November 03, 2021
From PAVmed Inc. and Lucid Diagnostics Inc.
Via Business Wire
News headline image
Veris Health Showcased in PAVmed Digital Health Virtual Investor Event
October 29, 2021
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award
October 28, 2021
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer
October 25, 2021
From PAVmed Inc.
Via Business Wire
News headline image
ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
October 21, 2021
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
October 21, 2021
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
October 18, 2021
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
How The Future Looks For Last Week's Biggest Losers: Futu, Regulus Therapeutics And More ↗
October 18, 2021
Last week, the five biggest stock market losers declined between about 36% and 26%. Below is a look at each stock and what they may have in the cards going forward. What To Watch... 
Via Benzinga
News headline image
Lucid Diagnostics Announces Pricing of Initial Public Offering
October 13, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
October 07, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed to Host Digital Health Virtual Investor Event
September 30, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner
September 21, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed to Participate in September Investor and MedTech Conferences
September 07, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
August 12, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers
August 10, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference
August 05, 2021
From PAVmed Inc.
Via Business Wire
News headline image
Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
August 03, 2021
From PAVmed Inc.
Via Business Wire
News headline image
CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021
August 02, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed to Hold Business Update Conference Call on August 12, 2021
August 02, 2021
From PAVmed Inc.
Via Business Wire
News headline image
Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors
July 28, 2021
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealth
July 22, 2021
From PAVmed Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap